Top 2% of genome-wide polygenic score indicates 3 times the risk of CKD

A new genome-wide polygenic score was able to determine the risk of chronic kidney disease (CKD) in patients with a score in the top 2%. A study published in naturopathy found that genetic testing using a genome-wide polygenic score (GPS) can detect people at increased risk for chronic kidney disease (CKD) and also found that …

Top 2% of genome-wide polygenic score indicates 3 times the risk of CKD Read More »